kunjalsharma98
50+ Views

Europe Liposuction Devices Market Technology Progress, Business Opportunities and Analysis by 2027

Market Analysis and Insights: Europe Liposuction Devices Market

Europe Liposuction devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.8% in the forecast period of 2020 to 2027 and is expected to reach USD 4,568.22 million by 2027. Rising awareness of liposuction procedure via social media and technological advancement in liposuction devices are the major drivers which propelled the demand of the market in the forecast period.
Liposuction is a medical process that utilizes a suction system to extract fat from various parts of the body, such as the abdomen, breasts, thighs, arms, buttocks or neck. Such areas are often shaped by the Liposuction. Liposuction is also termed as lipoplasty and body contouring. The fat is extracted by means of a hollow tool, called a cannula, inserted under the surface. A strong high-pressure vacuum is applied to the cannula.
Get More Insights About Europe Liposuction Devices Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-liposuction-devices-market
Liposuction is frequently paired and done alongside other cosmetic surgical operations such as facelift, abdominoplasty (tummy tuck surgery), and breast reduction. This may permanently remove fat cells and change the body shape. Currently, it is the most widely used surgical aesthetic procedure across the globe. Liposuction equipment available today includes various technologies such as laser-assisted, ultrasound-assisted lipectomy, power-assisted lipectomy, suction-assisted lipectomy, radiofrequency-assisted lipectomy. Technology selection is guided by surgeon choice, and a patient's characteristics. Many technical advances also culminated in the development of experimental energy distribution experiments to reach only the undesirable adipose tissue and/or to induce skin retraction. Such advances have contributed to improved outcomes and expanded fat evacuation facility. The surge in obese population, introduction of advanced liposuction equipment along with the increasing knowledge of health and body image globally are the key factors driving the demand for liposuction devices.
The liposuction devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Europe Liposuction Devices Market Scope and Market Size

Liposuction devices market is segmented on the basis of product, type, gender, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
On the basis of product, the Europe liposuction devices market is segmented into instruments and accessories. In 2020, instruments segment is dominating the Europe liposuction devices market because with the increasing variety instruments, minimally invasive procedures for liposuction can be performed across several body areas including the abdomen, breasts, buttocks, visceral fat, hips, knees, thighs, arms, face, neck, and chin.
On the basis of type, the Europe liposuction devices market is segmented into suction-assisted liposuction, power-assisted liposuction, water jet assisted liposuction devices, twin cannula-assisted liposuction, radio frequency assisted liposuction devices, laser assisted liposuction devices, ultrasound assisted liposuction device and others. In 2020, laser assisted liposuction devices segment is dominating the Europe liposuction devices market as several companies specializing in laser treatment have also started focusing on applications in liposuction which is aiding the growth of the market.
On the basis of gender, the Europe liposuction devices market is segmented into male and female. In 2020, the female segment is dominating the Europe liposuction devices market due to growing social media.
On the basis of end user, the Europe liposuction devices market is segmented into hospitals, specialty clinics, dermatology centers, ambulatory surgical centers and others. In 2020, hospital segment is dominating in the Europe liposuction devices market because the capacity of hospitals is significantly higher as compared to those of other institutions performing liposuction procedures.
On the basis of distribution channel, the Europe liposuction devices market is segmented into direct tender, retail sales and third-party distributor. In 2020, direct tender is dominating in the Europe liposuction devices market because procurement of liposuction devices and accessories through direct tender is highly cost effective for healthcare providers as they are bought in under terms of contract for service at a relatively lower cost.

Europe Liposuction Devices Market Country Level Analysis

The liposuction devices market is analysed and market size information is provided by country, product, type, gender, end user and distribution channel.
The countries covered in the liposuction devices market report are the U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe.
Germany is dominating the European liposuction devices market with the increasing growing popularity of liposuction surgeries for fat removal. Moreover, Italy is growing with the second highest growth rate in the forecast period of 2020 to 2027 due to growing adoption of liposuction treatment by both male and female in the region. France is dominating the market due to technological advancement of the products and procedure present in the region.
The country section of the European liposuction devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Collaboration by the Player for Development of New Advance Wearable Sensors is Creating New Opportunities for Players in the Liposuction Devices Market
European liposuction devices market also provides you with detailed market analysis for every country growth in particular industry with liposuction devices sales, impact of advancement in the liposuction devices and changes in regulatory scenarios with their support for the liposuction devices market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Liposuction Devices Market Share Analysis
European liposuction devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to European liposuction devices market.
The major players covered in the European liposuction devices market report are
AbbVie Inc., Alma Lasers (A subsidiary of Sisram Medical Ltd), Cynosure LLC (A subsidiary of Hologic Inc.), Cutera, Eurosurgical Ltd., NOUVAG AG, Human Med AG, BLINK MEDICAL, Energist Ltd., Murray Surgical, INTERmedic Arfran, CANDELA CORPORATION, Lipogems International S.p.A., Innovia Medical and Genesis Biosystems, Inc., Solta Medical (A subsidiary of Bausch Health Companies Inc.), BTL Group of Companies and El.En. S.p.A. among other domestic and European players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Browse Trending Related Reports @
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Comment
Suggested
Recent
Cards you may also be interested in
Asia-Pacific Biopsy Devices Market Evolving Opportunities with Innovative Ideas by Key Players |2019-2026
Market Analysis: Asia-Pacific Biopsy Devices Market Asia-Pacific biopsy devices market is registering a substantial CAGR of 8.08% in the forecast period of 2019-2026. This rise in the market value can be attributed to the increasing incidents of cancer and increasing government initiatives. Market Definition: Asia-Pacific Biopsy Devices Market Biopsy is a medical test conducted to evaluate and eliminate the body's cancer tissue. Biopsy is often used to obtain tissue sample to diagnose the disease when a patient is presumed of having cancer. There are different kinds of biopsy used in cancer diagnosis, including skin biopsy, fine needle aspiration, vacuum biopsy, shave biopsy, incision and excision biopsy, and needle biopsy. In needles, mechanical biopsy devices and biopsy guides, along with technological advances in significant computed tomography (CT) and ultrasonography (US) imaging techniques, there have been constant improvements. Get More Insights About Asia-Pacific Biopsy Devices Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-biopsy-devices-market Market Drivers Increasing incidents of cancer, is driving the growth of the market Increasing government initiatives, is helping in the growth of the market Surging demand for minimally invasive surgeries, are the major factor for the growth of the market Technological advancement in the field of biopsy devices, drives the market growth Market Restraints Strict standards and regulation for the use of biopsy, hinders the growth of the market Expensive biopsy devices, also restricts the growth of the market Increasing complaints to breast cancer screening procedure, impeding growth of the market Segmentation: Asia-Pacific Biopsy Devices Market By Product Needle-Based Biopsy Instruments Core Biopsy Devices Aspiration Biopsy Needles Vacuum-Assisted Biopsy Devices Procedure Trays Localization Wires Other Products By Application Breast Biopsy Lung Biopsy Colorectal Biopsy Prostate Biopsy Other Applications By Guidance Technique Ultrasound-Guided Biopsy Stereotactic-Guided Biopsy Mri-Guided Biopsy Other Guidance Techniques By End User Hospitals Academic and Research Institutes Diagnostic and Imaging Centers By Country Japan China India South Korea Australia Singapore Malaysia Thailand Indonesia Philippines Rest of Asia-Pacific Know more about this report https://www.databridgemarketresearch.com/reports/asia-pacific-biopsy-devices-market Key Developments in the Market: In May 2019, FUJIFILM Corporation today announced that it has entered into an arrangement to purchase medwork GmbH, a firm that creates and sells tools for therapy and diagnostic endoscopy. Medwork creates, produces and sells in-house endoscopic tools. The firm offers a high quality of its products used in endoscopic procedures for bile ducts, pancreatic ducts and digestive tracts and a broad variety of apps including lithotrite, polypectomy and biopsy*, which are spread in Europe and Asia, including Japan. In January 2019, MobileODT, the maker of the Enhanced Visual Assessment (EVA) scheme, will work with Apollo Hospitals and Genworks to provide their FDA-cleared, mobile, smart colposcope. The project will implement the first large-scale Augmented Intelligence (AI) engine for use in the cervical cancer screening. This implementation will provide healthcare professionals with cutting-edge, yet a low-cost mobile technology connectivity to millions of women across the Indian subcontinent which previously had limited access to the life-saving cervical exams. Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/asia-pacific-biopsy-devices-market Competitive Analysis: Biopsy devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of biopsy devices market for Asia Pacific Key Market Competitors: Few of the major market competitors currently working in the Asia-Pacific biopsy devices market are BD, Devicor Medical Products, Inc., ARGON MEDICAL., SOMATEX Medical Technologies GmbH, , Scion Medical Technologies, LLC, STERYLAB S.r.l., EndoMed Systems Alle Rechte vorbehalten, TSK Laboratory Asia PacificB.V., B. Braun Melsungen AG, Cardinal Health, Siemens, General Electric Company, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Olympus Corporation, Medtronic, SRL Diagnostics among others. Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-biopsy-devices-market Browse Trending Related Reports @ · Elderly Care Market · Industrial X-Ray Market · Biopsy Devices Market · Blood Culture Test Market · Compression Therapy Market About Data Bridge Market Research: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: Sopan.gedam@databridgemarketresearch.com
How Impacted COVID-19 on U.S. Shale Gas in Chemical Industry ?
Impact of COVID-19 on U.S. Shale Gas in Chemical Industry INTRODUCTION Shale gas and shale oil are defined as natural gas & oil from shale formations. Shale is a type of sedimentary rock that is made up of very small clay particles and is highly porous in nature. It is formed in deep ocean water, lagoons, wetlands, and swamps where the water is still enough for extremely fine clay and silt particles to settle to the bottom. Since shale is a porous formation, it serves as both a source and a reservoir for unconventional hydrocarbons. The extraction of oil and gas from a shale formation involves mechanical stimulation. One such technique for stimulation is hydraulic fracturing or fracking. In the fracking process, cracks in and below the Earth's surface are opened and widened by injecting water, chemicals, and sand at high pressure. The combination of horizontal drilling and hydraulic fracking has made it possible to access vast quantities of shale gas that were previously uneconomical to generate. Natural gas output from shale deposits has given the United States natural gas industry a new lease on life. The demand for safe access to energy sources is growing globally. Shale oil and gas have played an important role in meeting global energy demand during the energy revolution and are expected to continue to do so for decades as society transitions to lower-carbon energy sources. The rapid growth of shale oil and gas contributes to increased supply stability and lower commodity prices. According to the United States Energy Information Administration (EIA), in the year 2011, the country’s estimated available natural gas resources totaled 2,552 trillion cubic feet (Tcf). Natural gas from shale deposits, which was once considered to be uneconomical, accounted for 827 Tcf of this resource total. In the year 2020, U.S. dry shale gas production was about 26 trillion cubic feet (Tcf), and equal to about 78% of total U.S. dry natural gas production. IMPACT OF COVID-19 ON U.S. SHALE INDUSTRY Shale oil and gas exploration have, in particular, given the US oil and gas industry new dimensions of development. It has also fueled significant investment in associated infrastructure for gathering, storing, and delivering hydrocarbons to both domestic and foreign markets. In less than a decade, the US shale industry turned the global energy landscape upside down and re-established the US as the global energy leader. The onset of a global pandemic and subsequent drop in oil prices, on the other hand, has taken the momentum out of the shale boom. Due to a sudden drop in demand, the shale industry has immediately self-corrected. Many oil and gas players succumbed to the economic shock resulted from the CoVID-19 and filed for bankruptcy. Chesapeake Energy, a shale leader and once second-largest gas producer in the United States, filed for Chapter 11 bankruptcy protection in late June. According to the United States Energy Information Administration (EIA), the crude-oil output from seven major shale formations in the United states fell by around 56,000 barrels per day (BPD) in August 2020 to just under 7.5 million BPD, which would be the lowest level in two years. The shale industry is closely looped in with the oil and gas industry. The recent downfall of the oil and gas industry during the pandemic has had a severe impact on shale output. Post pandemic, the shale industry peaked, but the industry as a whole lost money. Since 2010, the US shale industry has produced USD 300 billion in net negative free cash flows, damaged more than USD 450 billion in invested capital, and seen more than 190 bankruptcies. With the advent of the coronavirus, the future for shale producers has become even bleaker, with a new bankruptcy filing occurring every week or so in the last few months. The pandemic's effects will be felt far beyond the US shale industry. Despite accounting for less than 10% of global oil and gas output, US shale oil extraction activity accounts for 40% of global shale oil extraction activity and accounts for nearly 100% of the growth in US midstream and export-oriented refining and petrochemical sectors over the last decade. STRATEGIC INITIATIVES DURING COVID-19 · Organization of the Petroleum Exporting Countries (OPEC) agreed on a continuation of March production levels for the month of April, with the exception of Russia and Kazakhstan, which will be authorized to increase production by 130,000 and 20,000 barrels per day, respectively, at their most recent meeting · Saudi Arabia has also agreed to extend its one-million-barrel-per-day voluntary cut for the month of April. · Companies such as Chevron, Shell, Schlumberger, and others have taken initiatives to safeguard their workforce in the ongoing pandemic situation. CONCLUSION On Conclusion, the pandemic has placed the shale industry in a delicate spot as major players are forced to cut down the output. The potential energy landscape in the United States and around the world is highly complex, and its drivers are interconnected. In the not-too-distant future, a wave of consolidation in the US shale industry could be triggered by the poor financial position of many firms and the weak economic outlook. The continuous demand for a ban on fracking, coupled with the effect of COVID, has cracked the shale industry severely. Although, the historic evidence indicates that the shale producers operate more economically. In comparison to 2019, producers in the Permian Basin are saving roughly 20% on good costs.
Global Lateral Flow Assays Market Size By Product, By Application, By Geographic Scope, And Forecast
The Lateral Flow Assays Market report is analyzed on the basis of its market share by value and volume. The report includes regional, country, and global analyses of all Lateral Flow Assays segments. The study encompasses all the major geographies around the world that are influencing the Lateral Flow Assays Market. The major insights into the Lateral Flow Assays Market are dominating factors, potential growth opportunities, restraints, and challenges that are presented in the report. Reporting is supported by Porter's Five Forces Analysis, Competitiveness Analysis, Assessment of Key Features of the Competitive Landscape, and Product Analysis. The research methodology included in the report and the resulting data will meet the needs of your business. The investment research data offered in the report enables stakeholders and investors of the Lateral Flow Assays Market to focus on ongoing and upcoming investment opportunities and to draw their attention to investment scenarios in the Lateral Flow Assays Market. The strategic intelligence functions promote the expansion of your business and help to better understand the potential of different industries in the Lateral Flow Assays Market. The report provides qualitative and quantitative analysis of Lateral Flow Assays Market scenarios by geographies and the performance of the different regions. The research analysis study is customized to meet the business needs of market participants. Further, the report highlights specifications and challenges including multiple methodologies for extracting precise data and facts, in-depth interviews, and studies of the competitive landscape of the Lateral Flow Assays Market The report covers the following key players in the Lateral Flow Assays Market: Abbott Laboratories Abbott Becton, Dickinson, and Company Biomerieux Bio-Rad Laboratories Danaher Corporation Hologic Johnson & Johnson Qiagen Thermo Fisher Scientific PerkinElmer Siemens Healthineers Segmentation of Lateral Flow Assays Market: Lateral Flow Assays Market, By Product • Benchtop Readers • Digital/Mobile Readers • Kits & Reagents • North America • United States • Canada • Europe • Germany • France • U.K. • Italy • Russia Lateral Flow Assays Market, By Application • Hospitals and Clinics • Diagnostic Laboratories • Pharmaceutical and Biotech Companies End Users • North America • United States • Canada • Europe • Germany • France Lateral Flow Assays Geographic Market Analysis: - North America (USA, Canada, Mexico) - Europe (Great Britain, France, Germany, Spain, Italy, Central and Eastern Europe, CIS) - Asia Pacific (China, Japan, South Korea, ASEAN, India, rest of Asia Pacific) - Latin America (Brazil, rest of LA) - Middle East and Africa (Turkey, CCG, rest of the Middle East) The report highlights various aspects in the Lateral Flow Assays Market and answers relevant questions on the Lateral Flow Assays Market: 1. What are the best investment opportunities to bring new products to market and provide advanced services in the Lateral Flow Assays Market? 2. What value propositions are relevant to the client or market segment that a company should focus on when launching new research or investment funds in the Lateral Flow Assays Market? 3. What policy changes will help stakeholders strengthen their supply chain and demand network? 4. Which regions would need more products and services in certain segments during the forecast period? 5. What strategies have helped established players reduce supplier, purchasing, and logistics costs? 6. The C-suite perspective used to put companies on a new growth path? 7. What government measures are promoting the Lateral Flow Assays Market or what government regulations may call into question the status of regional and global industries in the Lateral Flow Assays Market? 8. How will the political and economic crisis affect the opportunities in the Lateral Flow Assays Growth Zones?
Particle Therapy Market worth USD 1,349 million by 2023 : Technological advancements in the field of Heavy Ion Therapy
The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments. According to the new market research report “Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) – Forecast to 2023“, published by MarketsandMarkets™, the global Particle Therapy Market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. Browse in-depth TOC on “Particle Therapy Market“ 80 – Tables 36 – Figures 138 – Pages Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137 The major factors driving the growth of the Particle Therapy Market are the growing global prevalence of cancer, growing adoption of particle therapy in clinical trials, advantages offered by particle therapy over photon therapy, and the increasing number of particle therapy centers worldwide. The pediatric cancer segment is expected to account for the largest share of the Particle Therapy Market, by cancer type, in 2018 Based on cancer type, the Particle Therapy Market is segmented into pediatric cancer, prostate cancer, breast cancer, lung cancer, head & neck cancer, and other cancers. The pediatric cancer segment is expected to account for the largest share of the Particle Therapy Market in 2018. The growing incidence of pediatric cancer and the high success rates and minimal long-term risks achieved with particle therapy are the major factors driving the growth of this market segment. Research applications to register the highest CAGR in the global Particle Therapy Market during the forecast period Based on applications, the Particle Therapy Market is segmented into treatment applications and research applications. The research applications segment is expected to witness the highest CAGR during the forecast period. Growing awareness about the research applications of particle therapy systems, development of cost-effective and technologically advanced diagnostic and therapeutic particle therapy systems, and increasing industry-academia collaborations in the field of research are the key factors driving the growth of this segment. Asia Pacific to dominate the Particle Therapy Market during the forecast period The Particle Therapy Market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to account for the largest share of the global Particle Therapy Market in 2018, and this trend is expected to continue during the forecast period. The Asia Pacific region is expected to offer significant growth opportunities for players operating in the Particle Therapy Market owing to the increasing healthcare expenditure and growing initiatives to promote the use of advanced particle therapy technologies in Asia Pacific countries. Request for sample pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137 The major players operating in the Particle Therapy Market are Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy plc (UK), and Danfysik A/S (Denmark). Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) – Global Forecasts to 2026 https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html Patient Positioning System Market by Product (Tables (Surgical Tables, Radiolucent Imaging Tables), Accessories), Application (Surgery, Cancer Therapy, Disease Diagnosis), and End User (Hospitals, Ambulatory Surgery Center) – Global Forecast to 2022 https://www.marketsandmarkets.com/Market-Reports/patient-positioning-system-market-12586699.html About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/particle-therapy-market.asp
Importance of Tailoring a Suit for Men and Women
Why Bespoke Made-for-You Suits Are Best to Wear Custom-tailoring is loved by many for obvious reasons. A bespoke suit tailored just for you offers a host of benefits. If you are picking a suit from suit shops, Adelaide, this write-up will surely inspire you to get yourself a tailored one. The thing is that clothes are more than mere fabrics. As we drape them, they give us comfort and confidence. When you look good, you also feel good and tend to think and perform nothing but good. Knightsman Bespoke Tailors is inspiring hundreds of men and women to go for tailored suits. Their profound styling knowledge and tailoring skills have reached bespoke suit-making to the next level. Our tailoring hub is located in the heart of the city. We have carved a niche in making well-designed mens tailored suits Adelaide. We understand that one size fits all is a myth. The best way to get a perfectly fitting suit is to get it tailored just for you. Benefits of Tailoring Suits – Too Big to Miss As said above, the benefits of tailoring a suit are too big to miss. Once you know the pros of tailoring, you would change the way you buy suits in Adelaide. Made For You: First and first, a tailored suit is just made for you. This is what makes tailored suits different from the ready-to-wear ones. A garment stitched following your body specifications will prove a better fit for you. Minor misfits in suits result in major discomfort. Moreover, you can select fabric and style of your own choice. This means maximum liberty of choosing fabric quality, style, and minute details. Also, custom-made women’s suits Adelaide in events and parties are bound to stand out from others. Value for your Expense: A ready-made suit might seem an economical way but it is only a half-truth. When you get a tailored suit, you improve your overall fit and silhouette. Moreover, a good quality fabric chosen by you will last longer. This means nothing but the best returns on your investment in the long run. We know that a cheap unfit suit is definitely what you are looking for. Comfort is Everything A tailored suit not only looks pleasing but also means comfort for you. As the clothing is designed for your body shape, posture, and choice, it is bound to make you sit, stand, and walk comfortably. There is no chance for a single miss when suits are tailored by Knightsman Bespoke Tailors. Not each body shape and size falls into the concept of average size. Hence there are rare chances for finding a perfect off-the-rack suit. If you go for a tailored one against shops in Adelaide wedding suit hire, you will easily know the worth of having your own fit. Save your Time: We might be contrasting popular norms but a tailored suit means saving time. Once you have found your best tailor in Adelaide, you will agree with this. There is no need to move from one store to another and from one rack to another. Sometimes you end up trying many and choosing none. While at Knightsman, you can just pick your fabric and the rest is simple. Quality is Supreme: Quality is the best benefit of tailoring a suit for both men and women. Custom clothing always stands for high quality. With off-the-rack clothing, it turns out to be different than what you thought. At Knightsman Bespoke Tailors, top-quality durable fabrics like linen or cotton, or satin are ready to be tailored. You pick your fabric and get your suit custom-tailored. Convey all your styles and choices in detail. Expert craftsmen will listen to your needs carefully to give you the best fits. As we conclude, we are glad to reiterate the different faces of Knightsman Bespoke Tailors. We excel in tailoring corporate suits in Adelaide as well as wedding suits. We also cover men's fashion accessories, men's shoes, women's suits, and more. We know unique tailoring styles for a variety of clothing of men and women. Staying in tune with the latest trends is our passion. We are equally passionate about the essence of traditional wear meant for special occasions. To Know More Visit Please Visit Our Website: https://www.knightsman.com.au/
Cung cấp, lắp đặt kệ kho vải cuộn chất lượng, giá rẻ
Ngành may mặc Việt Nam trong những năm gần đây ngày càng phát triển và dần chinh phục các thị trường trong và ngoài nước. Quy mô sản xuất ngày càng lớn kéo theo nhu cầu lưu trữ nguyên liệu vải ngày càng cao. Vì vậy, nhiều kho hàng được xây dựng để đáp ứng nhu cầu chứa vải cuộn làm nguyên liệu cho nghành may mặc. Để giúp bạn có được sự lựa chọn đúng đắn nhất, kệ kho trung tải mang đến các giải pháp kệ chứa vải sau. Những mẫu kệ chứa vải hiệu quả nhất được các doanh nghiệp lựa chọn Hầu hết các loại kệ hạng nặng, kệ trung tải đều có thể sử dụng để chứa hàng hóa vải cuộn cũng như thành phẩm của ngành may mặc. Tuy nhiên để đảm bảo tính ưu việt và tận tối đa của kệ chứa hàng mà các doanh nghiệp hiện nay đang sử dụng 4 loại kệ dưới đây trong các kho chứa vải cuộn cũng như các thành phẩm. 1. Kệ Selective cho kho vải lớn Kệ Selective được sử dụng phổ biến trong các kho vải lớn. Chúng phù hợp với những doanh nghiệp cần lưu trữ một lượng lớn cuộn vải. Bên cạnh đó, loại kệ này chứa được nhiều chủng loại hàng hóa, chúng sẽ là sựa lựa chọn tuyệt vời cho những nhà máy sản xuất đa dạng các mặt hàng vải, quần áo hay thời trang. 2. Kệ Drive In lưu trữ lượng lớn vải đồng nhất Nếu doanh nghiệp chỉ cần lưu trữ một chất liệu vải duy nhất, kệ Drive In sẽ là sự lựa chọn tối ưu. Mật độ chứa hàng của loại kệ này rất cao, có thể tận dụng đến 70% diện tích kho, do giảm tối đa không gian dành cho lối đi. Tuy nhiên, khả năng tiếp cận vải của chúng rất kém, nên chỉ phù hợp với một số doanh nghiệp sản xuất và sử dụng một loại vải. 3. Kệ kho trung tải chứa vải quy mô nhỏ Kệ trung tải mang ưu điểm tương tự như kệ Selective nhưng có tải trọng thấp hơn (tối đa là 900 kg/tầng). Thiết kế của chúng có sẵn mâm tole nên bạn có thể đặt trực tiếp vải lên kệ mà không phải dùng pallet. Kệ chứa vải này thường được sử dụng để lưu trữ các cuộn vải nhỏ, giúp tiết kiệm chi phí thay vì phải sử dụng kệ chứa hàng lớn. 4. Kệ thép V cho kho hàng nhỏ Đối với những kho hàng có quy mô nhỏ hơn, số lượng vải cần lưu trữ ít, có thể sử dụng kệ thép V. Tải trọng của chúng lên đến 150 kg/tầng, dễ dàng đáp ứng nhu cầu chứa hàng của doanh nghiệp. Ngoài ra, loại kệ chứa vải này dễ dàng tháo lắp và di chuyển, giúp bạn thay đổi kết cấu và vận chuyển chúng khi cần thiết. Đây là một trong những mẫu kệ kho phổ biến nhất trong các kho hàng dân dụng hiện nay. Ngoài sử dụng trong việc lưu trữ hàng hóa trong các kho hàng thì kệ còn được sử dụng với chức năng trưng bày hàng hóa. Lắp đặt kệ kho vải cần chú ý những vấn đề gì Trên đây là 4 loại kệ để vải tối ưu nhất cho không gian lưu trữ cho nhà kho sản xuất trong ngành may mặc. Mỗi loại kệ tùy theo không gian lưu trữ và kích thước thiết kế sẽ có cách tính giá khác nhau. Onetech dựa vào những thông tin bạn cung cấp như: mặt bằng kho, kích thước vải bạn lưu trữ, thông số pallet… để tìm phương án xây dựng tối ưu nhất cho kho hàng của bạn. Chúng tôi sẽ tiến hành tư vấn, lập bản vẽ và báo giá cụ thể. Chính vì nguyên nhân này nên các sản phẩm của Onetech không có giá niêm yết cụ thể. Tuy nhiên, để tạo điều kiện cho khách hàng dễ hình dung và ước tính chi phí đầu tư, chúng tôi cung cấp mẫu báo giá để các bạn có thể tham khảo. Báo giá tham khảo một số mẫu kệ dùng trong kho chứa vải Kệ kho Selective: 2.400.000 – 10.000.000 Kệ Double Deep: 2.900.000 – 12.000.000 Kệ kho Drive In: 2.400.000 – 11.000.000 Kệ v lỗ: 460.000-1.600.000
What COVID-19 Impacted on Level Sensors in Semiconductors and Electronics Industry ?
Impact of COVID-19 on Level Sensors in Semiconductors and Electronics Industry ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET COVID-19 originated in the city of Wuhan, China in 2019 and has been continuously spreading worldwide since then. It has been extended to more than 180 and the U.S. tops the list, followed by India, Brazil, France and Turkey. As of 16th July 2021, World Health Organization (WHO) reported 188 million positive cases worldwide, of which 4.06 million patients lost their lives to the virus. On a positive note, 172 million patients have recovered and 3.4 billion people have been vaccinated. The pandemic has put the lockdown, travel ban and business shutdown in most countries, impacting the global economy. All the significant industries face severe disruption such as a break in the supply chain, shut down of offices and manufacturing units and many more due to the pandemic. However, the demand for the level sensor has drastically increased in automation industries with large-scale manufacturing and storage of liquids or powdered materials. Level sensors play a crucial role in effluent tanks for wastewater management, distribution of clean water and pump stations for irrigation systems, increasing demand in the market. Also, the increase in demand of level sensors in the oil and gas sector has raised the market's growth. STRATEGIC DECISION BY MANUFACTURERS AFTER COVID-19 Manufacturers are making many strategic decisions to come back to the market post-COVID-19. The companies are conducting many research and development activities to improve the technology involved in level sensors. With this, the companies are bringing more advance and accurate sensors to the market. Also, the use of advanced level sensors by government authorities in water management has led to the market's growth. Many companies to increase their market reach and business has done partnership with other companies or acquired other companies. For instance, · Siemens introduced Sitrans LR250 PLA (polypropylene lens antenna) radar level measurement transmitter, a field-proven device delivering reliable level readings for inventory management or critical process control. The transmitter has HART (Highway Addressable Remote Transducer), Profibus PA, or Foundation Fieldbus protocols to support the digitalization journey. Also, the transmitter has proven to be a reliable performer for bulk liquid storage tanks, process vessels with agitators, vaporous liquids and low dielectric media. · In March 2020, TE Connectivity Ltd., a global industrial technology company with leading positions in connectivity and sensing solutions, completed the acquiring of First Sensor AG and held 71.87% shares of First Sensor. The acquisition helps to support the growth strategy of TE's sensors business and TE Connectivity as a whole. Also, the company will be able to expand its product base, including innovative solutions, market-leading sensors, connectors and systems, plus best-in-class capabilities. · ABB's AquaMaster flowmeters have helped The Metropolitan Waterworks Authority (MWA) to save water. The Authority produces and supplies drinking water to over 11 million people in Bangkok, Nonthaburi and Samutprakarn. Over 400 AquaMaster flowmeters actively serve the Bangkok Metropolitan area helping optimize the management of the water distribution network. GSM-SMS radio technology enables accurate, early warnings on leaks to the MWA central control room. With this, the company has provided a tool that offers high-resolution data that facilitates step testing, leakage detection and water network analysis in the Bangkok Metropolitan area. IMPACT ON DEMAND AND SUPPLY CHAIN The rapid adoption of level sensors in the energy and power industries leads to its growth in the market. The rise in the demand for automated industrial operations is indirectly inducing high demand for level sensors. The adoption of level sensors in the food and beverage industry has also increased the market growth rate. The increase in the contactless solution of the level sensor has raised its demand in the market. Also, the use of the level sensor in the oil and gas sector has augmented the market's growth. For instance, · In June 2021, Emerson has introduced the Rosemount 1408H Level Transmitter, a non-contacting radar device designed specifically for the food and beverage industry. Its features include a hygienic compact design, fast sweep technology, exceptional radar beam focusing and IO-Link communications, helping manufacturers optimize their operations' efficiency, reduce product losses and ensure food safety. The company has provided its clients with level measurement technology for applications that require stringent hygienic facilities and equipment. · In March 2021, KROHNE has introduced the AF-E 400 ultra-compact electromagnetic flowmeter for utilities and industrial automation applications. It is specially designed to fit in applications with little installation space, such as in cooling lines of welding equipment, bending machines and robots, or on chemical dosing skids. It features stainless steel housing and is suitable for continuous use at +90°C/ +194°F liquid temperature, allowing for very demanding cooling and hot water applications. Thus the company has provided an advanced electromagnetic flowmeter. · In October 2020, NOHKEN Inc. announced the release of Tuning Fork Level Sensor for liquids application. The sensor has excellent durability and is corrosion resistance, compatible with most of the liquids. Also, it has operation check and failure diagnosis functions. The sensor is also compact and has no mounting direction and AC/DC free supply power is available. The COVID-19 pandemic and the consequent lockdowns worldwide have massively disrupted global logistics and supply chains. This has caused new challenges for manufacturing and distribution operations. The increased restrictions on goods' movement have caused havoc in the industry. China, the world's largest manufacturer of raw materials and finished products, has shut down all the manufacturing units due to the spread of viruses. As the raw material was not supplied, level sensor manufacturers worldwide have to face the shortage of the material and could not cater to the customers' demand. CONCLUSION The level sensor market has tremendously evaluated in the last few years. The advancement in technology has provided higher accuracy, efficiency, easy installation and level sensor maintenance, leading to its growth in the market. The increasing use of the level sensor in the oil and gas industry has raised its demand in the market. The new advanced and accurate sensors in the market have increased the government sector's need for the level sensor. Also, the adoption of this technology in different industries such as food and beverage, power generation, chemical and others has led to the market's growth. Also, the contactless solution provided by the company has raised the demand for the level sensor in the market.
Cách lựa chọn khoá cửa điện tử phù hợp với cửa sắt.
Có loại khóa điện tử nào có thể lắp được cửa sắt không em? Cửa cổng nhà anh/chị là cửa sắt thì có thể lắp khóa điện tử không? Loại nào tốt, đẹp mà bền bỉ, nước mưa vào có làm sao không em? Đó là những câu hỏi mà DTS SMART nhận được nhiều từ khách hàng. Dưới đây là một vài mẫu khóa dành cho cửa sắt được sử dụng nhiều nhất hiện nay. Khoá điện tử EPIC ES – FF730G Epic ES FF730G vân tay 2 chiều sẽ là giải pháp an ninh hoàn toàn mới cho cửa nhà hay cửa cổng sắt. – Vân tay 2 chiều – Cách mở khoá “khác biệt” dành riêng cho cửa nhà hay cửa cổng (cổng sắt có nan): mở bằng cả vân tay và chìa cơ từ phía trong và vân tay, thẻ từ, mã số từ phía ngoài thay vì chỉ 1 như các sản phẩm thông thường khác. – Thiết kế chắc chắn, an toàn – Tính năng thông minh: mã số chủ, mã số ảo, chống sốc điện, báo động cháy nổ, đột nhập, tính năng Wifi hiện đại… Tham khảo giá tại: https://bit.ly/3hO6KjV Khóa điện tử Epic ES F300D – Khóa vân tay, mã số, thẻ từ, mở rộng Remote, Bluetooth và Smart Living – Đăng ký tối đa 100 vân tay, 200 thẻ RF. – Công nghệ nhận dạng vân tay Lưới quang học đọc 360 độ, đọc mọi góc độ, siêu nhạy, chống làm giả – Bảo mật bằng hai hệ mã: Mã chủ Master và mã thành viên User Tham khảo giá tại: https://five.vn/da-nang/khoa-van-tay-es-f300d-947718.html Khóa vân tay Yale YDR 414+ – Khóa cửa không tay cầm, -CHUYÊN DỤNG cho cửa 2 cánh. 4 cánh – Có 4 cách mở khóa: vân tay, mã số, mở rộng remote, và chìa cơ phòng trường hợp khẩn cấp Khóa có hai chế độ: – Cài được 01 mã số, 20 vân tay ở chế độ Safe – Cài được 03 mã số: Master,30 user, visitor và 20 vân tay ở chế độ security, quản lý vân tay bằng Master code – Thân khóa bằng hợp kim – Chức năng cảnh báo cháy nổ, chống trộm, chống hack Khóa điện tử có chịu được mưa gió không? Cách tốt nhất để bảo vệ các loại khóa cổng sắt được lâu và bền là nên sử dụng hộp bảo vệ bằng inox. Hộp bảo vệ sẽ giúp tránh các tác động của thời tiết như mưa, gió, cát bụi, … Liên hệ lắp đặt khoá cửa thông minh tại Đà nẵng : 0905528188
Asia-Pacific Elderly Care Market Dynamics, Opportunities, Drivers, Restraints, Future Trends and Growth Outlook 2020-2027
Market Analysis and Insights: Asia-Pacific Elderly Care Market Asia-Pacific Elderly care market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.2% in the forecast period of 2020 to 2027 and expected to reach USD 341,854.33 million by 2027. Increasing ageing population and increasing use of social media on home healthcare are the major factors enhancing the market growth. Due to multiple benefits of home healthcare such as nursing home, home care for geriatric population increases the growth of the market. The geriatric population growth rate is increasing in Asia where home healthcare may play an important role as it provides services to people at home; hence people are getting more inclined towards it. Get More Insights About Asia-Pacific Elderly Care Market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-elderly-care-market For instance, in February 2018, an article published by World Health Organization, it has been estimated that around 125 million of people were aged 80 years or older. Further by 2050, approximately 120 million of aged people will live in China alone. So increasing population in countries of Asia Pacific may grow the market of Asia-Pacific elderly care market. This elderly care market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal. Asia-Pacific Elderly Care Market Scope and Market Size Elderly care market is segmented on the basis of product type, service and application. The growth among these segments helps you to analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of product type, the market is segmented into pharmaceuticals and housing and assistive devices. In 2020, housing and assistive devices is expected to dominate the growth of the elderly care market as the need for assistive devices is higher in homecare of elderly patients and growing geriatric population which are not capable of self-assistance hence, fuels the growth of the market in the forecast period of 2020 to 2027. On the basis of service, the market is segmented into homecare, institutional care and adult day care. In 2020, homecare segment is expected to dominate elderly care market as homecare provides its services and solution to aged patients at doorstep and one does not need to visit hospital hence, geriatric population is getting dependent and finding comfort with this facility, which ultimately leads to growth of the market in forecast period of 2020 to 2027. On the basis of application, the market is segmented into heart diseases, respiratory, diabetes, osteoporosis, cancer, neurological, kidney diseases, arthritis and others. In 2020, heart diseases segment is expected to dominate the growth of the market due to the growing incidences of blood pressure, cardiovascular diseases, hyper tension amongst elderly patients, leading the growth of the market in the coming year. Know more about this report https://www.databridgemarketresearch.com/reports/asia-pacific-elderly-care-market Elderly Care Market Country Level Analysis Europe elderly care market is analysed and market size information is provided by country, by product type, service and application as referenced above. The countries covered in elderly care market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines and rest of Asia-Pacific. China dominates the Asia-Pacific elderly care market due to increasing geriatric population associated with the diseases among elderly population. The rapidly increase in ageing population and ageing-associated disease strongly suggest the need for home healthcare to address the treatment of older people in China. For instance, according to an article published by World Health Organization in 2015, China in Asia-Pacific region has high aging people than middle-income or low-income countries. They have also estimated that the population aged 60 years or older will increase from 12.4% in 2010 to 28.0% in 2040. Increasing aged population associated with diseases will require better care and home healthcare hence, china is dominating the Asia-Pacific elderly care market. The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. Strong Investment in Research and Development Activities and New Technology Penetration Asia-Pacific elderly care market also provides you with detailed market analysis for every country growth in medical device industry with elderly care sales, components sales, impact of technological development in elderly care services and changes in regulatory scenarios with their support for Elderly Care Market. The data is available for historic period 2010 to 2018. Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/asia-pacific-elderly-care-market Competitive Landscape and Elderly Care Market Share Analysis Asia-Pacific elderly care market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Asia-Pacific elderly care market. The major players covered in the report are · Right at Home, LLC · Koninklijke Philips N.V · Bayada Home Health Care · Econ Healthcare Group · Home Instead, Inc. · Econ Healthcare Group · Orpea Groupe · St Luke’s Eldercare Ltd. · Rosewood Care Group · Medtronic · Interim HealthCare Inc · United Medicare Pte Ltd among other players in Europe. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-elderly-care-market Browse Trending Related Reports @ · Biopsy Devices Market · Industrial X-Ray Market · Blood Culture Test Market · Compression Therapy Market · Cosmetic Threads Market About Data Bridge Market Research: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: Sopan.gedam@databridgemarketresearch.com
How Impacted COVID-19 on Neural Implant in Healthcare Industry ?
Impact of COVID-19 on Neural Implant in Healthcare Industry The COVID-19 pandemic has stood as a complex challenge in front of several healthcare companies and proved to be a global health threat. The first case of the COVID-19 pandemic was found in Wuhan, China. This virus had emerged in December 2019 and has been proven as a global pandemic by WHO in March 2020. Patients with other respiratory disorders such as Chronic Bronchitis, Lung Cancer, and Pneumonia are more susceptible to COVID-19. This pandemic has created a health crisis, and it has adversely affected our economies, healthcare and pharmaceutical sectors, and their core. As the number of COVID-19 (coronavirus) cases continues to rise in the U.S., Russia, France, and Brazil, life-threatening and rare brain diseases are being linked to the infection. This has brought companies in the brain implants market into the picture since their assistance is crucial in the already stressed healthcare facilities. Neural implant technology is highly innovative and is expected to influence the existing treatment modalities of neuropathic disorders and chronic neuropathic pain. The introduction of neural implants has been a significant breakthrough because of their high potential in minimizing the occurrence of adverse events associated with Parkinson's disease, chronic pain, epilepsy, and other neural disorders. Therefore, the adoption of neural implants is likely to increase at a phenomenal rate in the coming years. Healthcare professionals were often redeployed to emergency patterns of working, sometimes outside of their usual scope of practice. Thus, the urgent and routine care for millions of patients with non-COVID illnesses has been interrupted. IMPACT ON DEMAND The COVID-19 pandemic is expected to have a significant impact on the growth of the brain implants market globally, due to the suspension and postponement of most of the elective surgeries and treatment during the pandemic, to reserve the hospital infrastructure and staff in treating COVID-19, infected patients. According to the research article published in medRXiV, 2021, the prevalence of SARS-COV2 viral infection in patients with Parkinson's disease was found to be 11.28% and COVID-19 prevalence in Parkinson's disease patients with deep brain stimulation was found to be 18.18%. Additionally, as per the research study published in Frontiers in Neurology, 2020, the motor and psychiatric symptoms in Parkinson's Disease patients and dystonic patients treated with Deep Brain Stimulation was observed to have worsened during the lockdown restriction measure, and further, this had led to increased stress in the management of neurological disorders. Additionally, according to the research article published in JAMA Neurology, 2020, among 214 patients with COVID-19, neurologic symptoms were seen in 36.4% of patients. Thus, patients suffering from COVID-19 are prone to a high risk of developing neurological disorders during their hospital stays. Thus, owing to the strict lockdown restrictions and measures taken to contain the viral transmission, the chronic stress and burden of neurological disorders had increased, which required the urgent opening of the neurological outpatient services, and thus, the brain implants market is expected to have impacted significantly during the pandemic. The increase in the number of cases of neurological disorders, such as Alzheimer’s, epilepsy, Parkinson’s, depression, and essential tremors, is anticipated to propel the demand for brain implants. Brain implants are likely to reduce the need for drugs that relieve chronic pain and improve body movement in patients suffering from Parkinson’s or any other neurological disease. The growing geriatric population is also prone to order surgical disorders and thus, aging is the major factor that is driving the market growth for brain implants. According to the United Nations, World Population Ageing 2019 report, more than 703 million people were aged 65 years and above in 2019 and are expected to reaching 1.5 billion by 2050. IMPACT ON SUPPLY Due to the pertinacious COVID-19 lockdown in various countries, sanctions have been forced by administrations of different nations. These limitations and boundaries across the nation’s borders prompted a diminishing stockpile because of restricted materials and labor force and the halting of the assembly line. It has been found that certain individuals in their late ’50s are at risk of developing acute necrotizing encephalitis, which is a rare complication of influenza and other viral infections. This has fueled the growth of brain implants to maintain steady supply chains to meet the demand. Acute necrotizing encephalitis has the potential to cause seizures and confusion, and in serious cases, can lead to coma. This has triggered the need for developing strong research databases to address complications of COVID-19. STRATEGIC DECISIONS BY MANUFACTURERS The presence of key players in the region and the increasing number of product approvals is expected to drive the studied market growth. For instance, · In June 2020, US FDA approved Medtronic plc's Percept deep brain stimulation (DBS) for the treatment of Parkinson’s symptoms. The major market players are focusing on technological advancement to acquire maximum market share. For instance, · In January 2021, Abbott Laboratories launched its NeuroSphere my Path, a Digital Health app that was developed to track and report on pain relief in chronic pain patients and general well-being associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy. · In March 2021, Abbott Laboratories announced the launch of NeuroSphere Virtual Clinic, which is a remote neuromodulation patient-care technology in the United States. · In March 2020, LivaNova plc received CE Mark approval for its Vagus Nerve Stimulation Therapy (VNS Therapy) System, "Symmetry", for Difficult-to-Treat Depression (DTD). · BrainCom— a collaborative research project that aims to develop a new generation of neuroprosthetic devices is being funded by the European Union under the FET Proactive funding scheme to advance speech neural prostheses. Companies in the brain implants market are increasing the availability of solutions for people suffering from motor diseases and neurological conditions. Such implants are bolstering market growth, as they have the potential to eliminate the need for open brain surgeries. · Dell Technologies— a U.S. multinational computer technology company is gaining strong business grounds in transformative technologies for brain implants by collaborating with think tanks and neuroscientists. In June 2018, Medtronic plc announced that the US Food and Drug Administration approved Deep Brain Stimulation (DBS) Clinician Programmer and Activa(TM) Programming Application. The Activa Programming Application has been uniquely designed with the input of over a hundred clinicians from around the world and is managed on the Samsung Galaxy Tab S2 tablet interface. In February 2016, ALEVA NEUROTHERAPEUTICS SA announced a collaboration with Greatbatch for a next-generation device for Deep Brain Stimulation (DBS). Under the terms of the development agreement, Greatbatch’s design and development team QiG Group, which is expected to be spun off as Nuvectra Corporation, will provide Aleva with access to its unique implantable neurostimulation platform. Companies in the brain implants market are increasing the availability of less invasive solutions since the brain is one of the most delicate and sensitive body organs. They are decoding the symphony of neural activity to stimulate brain function. CONCLUSION Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Brain Implants market in 2020.
What COVID-19 Impacted on Bulk Material Handling System in Semiconductors & Electronics Industry ?
Impact of COVID-19 on Bulk Material Handling System in Semiconductors and Electronics Industry The lockdown situation during the COVID-19 pandemic has highly impacted the global economy. Most of the governments from different countries imposed a lockdown to break the chain of coronavirus spread. All companies related to various industries have been shut down except a few dealing with COVID-19 operations such as pharmaceutical, essential goods and services and the food industry. As a result of the COVID-19 crisis, many bulk material handling companies throughout the world have had to either temporarily close or reduce their workforces to prevent the spread of the virus. Through worldwide shoartages of goods, it soon was apparent how important the world’s manufacturing and warehouse productivity is to the economy. In the bulk material handling system market, the business impact eventually proved to be less severe than first anticipated once lockdowns and restrictions were lifted. Nevertheless, the limited access to customers’ sites affected both capital and aftermarket sales of suppliers throughout the year. The COVID-19 pandemic highlighted that automation is needed for supply chains to increase efficiency. During the recent period, very few percent of supply chains felt fully prepared for the coronavirus impact. However, the bulk material handling industry can develop this situation with innovation, automation and perseverance. OPPORTUNITIES FOR THE MARKET IN COVID-19 SITUATION Market players have an opportunity to upgrade their operations and prospective for the betterment of their companies. Automation is the key to success in this unpredictable world. Different crises, labour shortages, natural disasters impact a lot on every industry. So being one step ahead of time and understanding the market well will ensure the success of the market player. In this COVID-19 pandemic, many companies adopted process automation and customization as an opportunity to survive and grow. Some of the instances are mentioned below: § Automation to overcome labor shortage: Though recent events have worsened the labor gap, the labor shortage is not new for many industries, as more workers retire and skills requirements increase. Automation offers solutions to some of these problems. Automated Process Equipment Corporation provides solutions and services for bulk material handling companies to overcome labor shortages during this pandemic situation. Super sack handling, accurate measuring, automatic routing, easily reprogrammable controls and electronic record keeping are solutions that will improve automation and reduce the dependency on the massive number of laborers. § Customized Solutions for Booming Market: KWS Manufacturing Company Ltd. partnered up with Coperion K-Tron to provide the solution for the world’s most significant high-density polyethylene and polypropylene suppliers, which is used in consumer and industrial goods ranging from plastic bags and bottles to N95 medical masks and face shields. Due to the increased demand for polyethylene and polypropylene, expanding the client’s extrusion line required new loss-in-weight additive feeders and a mixing screw conveyor. KWS and Coperion K-Tron sales and engineering teams collaborated to ensure the extrusion line expansion would be successful. IMPACT ON SUPPLY AND DEMAND COVID-19 has disrupted the supply chain on a global scale. International trade restrictions and customs regulations resulted in longer wait times and a lack of capacity for long-haul deliverables. During this pandemic, the demand for bulk material handling solutions decreased because of the limited access to customers’ sites. This affected both capital and aftermarket sales throughout the year. Most of the companies faced challenges in managing on-time project completion and order deliveries. However, many companies took this to redesign their operation and logistic models with digital capabilities to increase operational efficiency and effectiveness in such a period. For instance, · ThyssenKrupp AG Company adopted the digitization of their business processes and supply chains in 2019-2020. Their focus was on the introduction of automation solutions which included the new mobile app “Paperless”. This app allowed digitizing day-to-day processes in warehouses such as bookings, preparation of work schedules and material identification. It also created the conditions for using other automation solutions, such as driverless transportation systems, to be used in a new state-of-the-art logistics center for ThyssenKrupp Schulte. Such positive changes and automation in the supply chain will enable the companies to emerge stronger and supply chains that are more resilient to future disruptions. AFTERMATH OF GLOBAL BULK MATERIAL HANDLING SYSTEM MARKET COVID-19 pandemic affected a wide range of industries, from small to large manufacturing companies. It hampered the worldwide demand for solutions in the bulk material handling system market up to a certain extent. Limited workforce and operational restrictions negatively affected the product development life cycle. But at later stages, when lockdown restrictions were lifted, demand got stable up to a certain point. The companies developed different strategies and technologies specific to tackle problems that occurred because of the COVID-19 pandemic. For instance, · Daifuku Co., Ltd., a material handling company, stated some measures and strategies to overcome the challenges faced during the COVID-19 pandemic in their annual report 2020. To prevent the spread of COVID-19 and maintain distance from one another required a new approach to service activities for systems post-delivery. Accordingly, they are working hard to use the Internet of Things (IoT), artificial intelligence (AI) and information and communications technology (ICT) to establish material handling systems that never stop or that will be able to recover immediately even if blocked. They will continue to support stable operations of customer facilities by introducing new technologies and services, including remote operation, while ensuring the lives, safety and health of employees and their families. Likewise, many companies have started introducing new technologies and methodologies in the COVID-19 situation to remain better positioned in the market. Losses during this period can be overcome in the future by taking this slowdown to redesign and refresh the business processes and logistics operations. CONCLUSION The global bulk material handling system market suffered losses during the recent period because of COVID-19’s negative impact on global demand and supply chains. Yearly sales for the market-related products got hampered due to limited access to customer’s sites. But relaxation in lockdown regulations after few months helped the market to somewhat come back on track. However, many companies started building new technologies to overcome supply chain problems in pandemic situations. They adopted digitization and automation in day-to-day business processes and supply chains. Although it will take some more time for companies to come back on track, this period made everyone realize the need for up-gradation in many business aspects.
Khóa cửa vân tay giá bao nhiêu tiền
Khóa cửa vân tay giá bao nhiêu tiền là câu hỏi được nhiều khách hàng quan tâm tìm hiểu. Qua bài viết này chúng tôi xin đưa thông tin một số sản phẩm khóa vân tay để khách hàng có thể tham khảo. Lưu ý là giá tham khảo tại thời điểm bài viết. Khoá cửa vân tay hay khóa vân tay được biết đến như một loại khóa cửa an ninh tốt nhất hiện nay, không chỉ mang lại tính năng vượt trội như: Khóa không cần chìa cơ mà còn tự động khóa cửa khi ra khỏi nhà tránh trường hợp quên khóa cửa. Khóa cửa vân tay còn mang lại sự An toàn, tiện dụng và sự sang trọng cho ngôi nhà. Khi có một loại thiết bị tốt với nhiều chức năng như vậy, nhiều người đã rất quan tâm và muốn tìm hiểu khóa bằng vân tay giá bao nhiêu tiền. Để biết được giá của các loại khóa vân tay không khó. Mời điểm qua giá các loại khóa cửa vân tay từ thấp đến cao (tham khảo giá tại DTS SMART 1. Khóa thẻ từ không tay cầm của Samsung 2920 Giá tham khảo: 3.500.000 vnđ Khóa cửa điện tử Samsung SHS-2920 Loại khóa cửa không tay cầm Sử dụng: Mật mã, thẻ từ ( tối đa 40 thẻ, đi kèm ban đầu 4 thẻ) Màn số cảm ứng Chế độ tự khóa hoặc manual Cảnh báo khi có hiện tượng cháy nổ, phá khóa. Nguồn: 04pin AA Vật liệu: Hợp kim Màu sắc: đen Có 2 điểm cực tiếp nguồn khẩn cấp khi hết pin không kịp thay Cửa phù hợp: Đố cửa dày tối thiểu 3.5cm, rộng tối thiểu 7cm Xuất xứ: Hàn Quốc 2. Khóa cửa vân tay có tay cầm của Gateman F20 Giá tham khảo 4.500.000 vnđ Thông số kỹ thuật – Kích thước: + Mặt trước: 64.6(w) X 160.2(H) X 19(D) mm + Mặt sau: 85(w) X 158(H) X 36(D) mm – Đăng ký lên tới 20 dấu vân tay thường và an ninh cao cấp – Quản lý cài đặt ID vân tay và User mật mã – Cài đặt 1 mật mã Master chủ và 30 Mật mã phân quyền – Cài đặt Mã số sử dụng 1 lần thông qua Master chủ – Xóa cài đặt mã số, vân tay thông qua Master chủ – Hướng dẫn cài đặt bằng giọng nói ngôn ngữ tiếng Anh mặc định – Thông báo đóng, mở cửa bằng giọng nói tiếng Anh – Công nghệ quét vân tay Live – Scan – Chức năng thoát hiểm từ bên trong – Chức năng tự động khóa – Chức năng tự động tái khóa – Lựa chọn khóa tự động hoặc bằng tay – Âm báo trạng thái đóng, mở cửa – Chức năng cảnh báo Pin yếu – Chức năng báo cháy – Chức năng mã bí mật để dự phòng – Dành cho cửa dày từ 40mm-50mm – Xuất xứ: Hàn quốc 3. Khóa cửa điện tử Samsung SHS-H505 Giá tham khảo 5.100.000 vnđ – Khóa cửa điện tử kỹ thuật số có tay cầm. – Màn hình cảm ứng chống trầy, chống va đập – Mở khóa bằng mã số, thẻ không tiếp xúc hoặc bằng chìa khóa cơ. – Có thể mở rộng thêm để sử dụng Remote điều khiển đóng mở cửa. – Bàn phím cảm ứng kỹ thuật số với mã số bảo mật ngẫu nhiên – Độ dài mã số mở cửa từ 4 đến 12 số. – Thẻ sử dụng RFID ISO 1443A Type (13.56MHz) – Số thẻ sử dụng tối đa 20 thẻ. – Chức năng tự động khóa khi đóng cửa. – Báo động khi có đột nhập hoặc hỏa hoạn. – Chức năng điều chỉnh âm thanh thông minh (Đặc biệt hiệu quả khi có em bé đang ngủ hoặc mở cửa vào ban đêm). – Nguồn điện: 12VDC (8 Pin AA), sử dụng khoảng 12 tháng (10 lần đóng mở cửa/ngày). Nguồn khẩn đấu ngoài dùng 9VDC. – Chức năng báo Pin yếu: Âm thanh và ánh sáng phát ra khi mở cửa. – Chức năng bảo vệ chống tĩnh điện ESD (Electro Static Discharge), bảo vệ khóa không bị phá hủy khi bị nhiễm điện áp cao. – Thân khóa bằng hợp kim. – Kích thước: 81x302x20mm – Sử dụng Mortise: SHS-AML220 (25 x 110 x 106mm) – Màu đen. Yêu cầu tiêu chuẩn đối với cửa lắp đặt: –Độ dày cửa từ 38mm – 52mm – Độ rộng của đố cửa > 115mm + Khóa cửa vân tay O’lok 7900 Giá tham khảo 7.900.000 vnđ Khóa cửa vân tay O’LOK H7900  Loại khóa cửa vân tay thiết kế chắn chắn hiện đại và tiện lợi.  Sử dụng: Vân tay, mật mã, thẻ từ, chìa cơ (03), remote ( option).  Chức năng tạo mã giả thông minh, màn hình hiển thị thân thiện, xem lại lịch sử ra vào.  Đầu đọc vân tay bán dẫn siêu nhạy và an toàn khi sử dụng.  Đăng ký tối đa 150 vân tay, 150 mật mã, 150 thẻ từ.  An ninh: cảm biến đột nhập, cảm biến hỏa hoạn  Hướng dẫn sử dụng, báo hiệu bằng giọng nói ( tiếng Anh).  Vật liệu: hợp kim Inox 304, NZ plastics  Nguồn: sử dụng 4 pin AA 1.5V  Có điểm tiếp nguồn ngoài khẩn cấp Màu sắc: các màu bạc, vàng. + KHÓA CỬA VÂN TAY YALE YMG40 GIÁ tham khảo: 18.000.000 VNĐ Khóa cửa vân tay Yale YGM40 Loại khóa cửa vân tay thiết kế đẩy kéo hiện đại và tiện lợi. Sử dụng: mật mã, vân tay, chìa cơ (02), remote ( option) Chức năng tạo mã giả thông minh Công nghệ scan vân tay siêu nhạy và an toàn. Đăng ký tối đa 20 vân tay, 30 mật mã An ninh: cảm biến đột nhập, cảm biến hỏa hoạn Hướng dẫn sử dụng, báo hiệu bằng giọng nói ( tiếng Anh) Vật liệu: hợp kim nhôm, NZ plastics Nguồn: sử dụng 4 pin AA 1.5V Có điểm tiếp nguồn ngoài khẩn cấp Kích thước: Thân ngoài: 76×359,1×67,6mm Thân trong: 76,5×359,1×65,2mm Màu sắc: các màu trắng, đỏ đồng hoặc vàng DTS SMART– Khóa Vân tay Đà Nẵng uy tín nhất – Hotline : 0905 528 188. Chúng tôi sẵn sàng phục vụ. Xem thêm : Cách lựa chọn khoá cửa điện tử phù hợp với cửa sắt.
How Impacted COVID-19 on Intelligent Vending Machines in Semiconductors & Electronics Industry ?
Impact of COVID-19 on Intelligent Vending Machines in Semiconductors and Electronics Industry The pandemic begins with its epicenter in China in 2019 and has been continuously spreading by then to all over the globe, so far 216 countries and territories have been affected with COVID-19. The COVID-19 cases reaching to various countries which have strong dominance in the worldwide market and have adversely affected the economic growth globally. The spread of coronavirus has led to severe disruption such as global recession, many organizations are being forced to take stringent actions as lying of their employees and staffs, small and medium business is being shut down, and manufacturing & production facilities are being put on hold for a longer period. However, apart from this, the demand for food and beverages witnessed huge growth but this has increased the shortage of supply chain due to the panic buying from the populations. Similarly, the demand for the pharmaceuticals, chemical, and healthcare industry also increased as new solutions and medicines are getting introduced for taking preventive measures. There has been a disruption in the supply chain of many industries due to restrictions in logistics and the closing of manufacturing facilities. In addition, the slowdown in the economy has lowered the spending capability of individuals and people are saving money for emergencies. The intelligent vending machines are controlled by a computer and backed by a cloud-based management system. The cloud allows for live inventory monitoring and sales data that was previously unavailable or extremely delayed. Vending machines have evolved into a new class of automated retails kiosks with the use of modern technology. The range of products that can be dispensed by these machines is unbelievable. A custom vending machine can also be created that can be customized to the products that are dispensed. STRATEGIC DECISIONS FOR SERVICE PROVIDERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE The market players are now taking many strategic decisions to gain their market share and profit after COVID-19. Strategic decisions such as mergers & acquisitions and technological innovations are helping market players to regain their share. The companies are converting their intelligent vending machines into unmanned retailers with limited space and this strategic decision will help the companies to boost their sales as these kinds of vending machines are capable of dispensing any goods irrespective of their size and shape. The integration of IoT in vending machines will help companies to increase their sales. DEVELOP NEW SOLUTION The Intelligent vending machines will need to be staffed differently to cater 24*7 to provide service. The companies are developing new solutions by strategic partnership and collaboration. OFFER NEW SERVICES TO MANAGE THE INTELLIGENT VENDING MACHINES SOFTWARE The companies are trying to offer new services to the customers with the help of new strategies and opportunities and also due to recent development in vending machine products and services. By maximizing the operational opportunities to minimize the cost, the companies are investing in R&D to improve their services. The use of vending machines allows businesses to operate 24 hours a day 7 days a week. OTHER GROWTH OPPORTUNITIES FOR MARKET PLAYERS TO PURSUE IN 2020 The vending machines and micro-markets leave a space for a solution that has significant potential growth. This type of machine will include a full micro market with a reasonably large number of SKUs. Several North American and European operators are offering such solutions. AFTERMATH STRATEGIES FOR INTELLIGENT VENDING MACHINES MARKET AND GOVERNMENT ROLE The COVID-19 pandemic was not predicted by any government to be ready for. The pandemic resulted in many changes brought by the government to the usual norms of operations for multiple industries around the world. The pandemic affected the market and consumer behavior, this created volatility in the economy. Smart vending machines are the next evolution of retail because they allow the business to reach customers in new locations and new ways. They also serve customers with ease and efficiency by only displaying what selections are in stock. For instance, § Vending machines of Azkoyen will be installed in the new AVLO trains, the low-cost high-speed train. These vending machines will provide drinks and snacks to more than 400 Avlo passengers with their automation. OPPORTUNITIES FOR THE MARKET IN COVID-19 SITUATION To improve and reinforce the services of traditional vending machines, AAEON has provided an intelligent solution to facilitate their functions. Ideally, smart vending machines integrate seamlessly with important systems including commerce, ERP, operations, and inventory management. The industry is now growing towards API-driven, headless commerce supports integration with any touchpoint. For instance, · The smarter solution, called brainy, offers an exceptional shopping experience. Along with the coming of the Internet of Things (IoT) age and its increasing prevalence in our daily lives, Brainy supports Intel Realsense technology through AAEON’s “UP” board, a credit-card-sized single-board computer. IMPACT ON DEMAND The pandemic has caused a decrease in demand for vending machines. With the fast converting life of the population and digitalization in vending machines such as IoT, the companies are under the transformation of their products such as cashless payments and safe products delivery which will eventually help in increasing demand. The COVID-19 has impacted the demand for the vending machines as the employees started working from home. 80% of the vending machines were majorly located at offices and workplaces which are closed and ultimately causing a failing economic activity. The healthcare industry has not seen a much decline in vending machines as they are essential for healthcare personnel. The overall COVID-19 has impacted the demand for vending machines negatively. For instance, · The Azkoyen Group, a leading Spanish technology offers automated vending machines has received an award. The award is regarding the best vending machine supplier and has great technology of automation. IMPACT ON SUPPLY CHAIN The COVID-19 pandemic has affected the market but the services are now shifted towards cloud platform which is very easy and flexible to use. These cloud platform services also save the cost of the companies as they are paying as you use services but this has increased intelligent vending machines and services. The COVID-19 has also affected the supply chain of intelligent vending machines which results in the loss of the industry. Due to lockdown imposed by the states and taking into consideration the safety, the installation of the intelligent vending machines was on hold as the supply chain was hampered. The cost of supplying machines and their spare parts were also increases which ultimately increases the prices of intelligent vending machines. IMPACT ON PRICE The lockdown imposed by the government of the countries had adversely impacted the prices of the intelligent vending machines services due to the implementation of remote working. The prices of the services have been increased as the software has been shifted to the cloud which has resulted in increasing physicals security. The prices of the vending machines have been increased as now the traditional vending machines have been replaced by automated vending machines which incurred high cost and ultimately affect prices. A vending machine is a retailer with limited space and such engineering requires high cost which will increase the prices of the intelligent vending machines. CONCLUSION The micro-markets are not only for traditional vending machine operators. By the nature of operations and data management, the micro-market can be an ideal solution for retailers wishing to expand beyond the store and allow customers 24/7 availability of the products. The digitized systems, equipped with a large number of sensors and available data will become a rich source of data to be analyzed for the stakeholders which will help in finding trends and growth. The different innovations in vending machines such as the integration of IoT which supports cashless payments, safe delivery are the market opportunities. Companies are now simplifying convenience by using such technological innovations. The market is now moving towards unmanned retail stores due to pandemics which can be a great opportunity for the vending machine market as they can deliver goods and any packaging units. The growth of the market will be slow after the pandemic but it will surely rise and will gain popularity.
Jasa Pengiriman Bandung Tanjung Pura, Langkat (0816267079)
Bingung mencari Jasa Ekspedisi dan Pengiriman Barang yang terjangkau namun aman pengiriman sampai ke alamat tujuan ? Dapatkan kemudahan pengiriman dan tarif terjangkau di Logistik Express Jasa Pengiriman Bandung Tanjung Pura, Langkat Logistik Express Jasa Pengiriman Bandung Tanjung Pura, Langkat merupakan perusahaan yang menyediakan jasa pengiriman barang ke seluruh wilayah Indonesia. Kami menyediakan pengiriman melalui via darat, laut, maupun udara yang tentunya dengan tarif yang terjangkau dan pengiriman yang aman.Adapun beberapa pelayanan yang LOGISTIK EXPRESS yang dapat kami berikan kepada anda : Melayani Pickup Area Bandung dan Kab. Bandung sekitarnya. Pengiriman barang sampai ke alamat tujuan. Jasa Pengiriman ke Seluruh Wilayah Indonesia Layanan Muatan Cargo Besar Minimal 30Kg, 50kg, dan 100kg Seluruh Indonesia. Bisa Request Packing kiriman Kirim barang dengan Logistik Express Jasa Pengiriman Bandung Tanjung Pura, Langkat tentu murah tentu mudah. Dibantu dengan team operasional yang handal dan customer service profesional LOGISTIK EXPRESS siap mengirimkan barangmu sampai ke alamat tujuan dengan aman. Layanan Customer Service & Order : 0816267079 Cek layanan pengiriman dari Bandung lainnya : Ekspedisi Bandung tanjung pura Ekspedisi Bandung tanjung redeb Ekspedisi Bandung tanjung selor Ekspedisi Bandung tanjung uban Ekspedisi Bandung tanjung Ekspedisi Bandung tapak tuan Ekspedisi Bandung tarakan Ekspedisi Bandung tarempa Ekspedisi Bandung tarutung Ekspedisi Bandung tasikmalaya
How COVID-19 Impacted on Nivolumab in Healthcare Industry ?
Impact of COVID-19 on Nivolumab in Healthcare Industry COVID-19 (Coronavirus) has affected the day-to-day life of people and has slowed down the economies worldwide. The pandemic has affected millions of people who either got sick or died due to the spread of this disease. Within a few months, coronavirus disease (COVID-19), which originated from China, became a pandemic, with more than 30 million people being infected till date. There are now numerous vaccines in use. The first mass vaccination program commenced in early December 2020, and as of 15 February 2021, 175.3 million vaccine doses have been administered. There is an added complexity because of COVID-19 diagnosis in cancer patients, particularly while on active treatment with immunotherapy like nivolumab. COVID-19 could cause more harm to cancer patients. In order to prevent the infection from spreading, the patient’s number and new diagnosis have been less during the COVID 19. The COVID-19 pandemic has led to a dramatic loss of human life worldwide and presents an unprecedented challenge to public health, food systems, and the world of work. Still, there is an increase in the demand for cancer treatment with immunotherapy drugs like nivolumab during the second quarter of 2020 with the rise in awareness regarding health and new product launches in countries. STRATEGIC DECISIONS BY MANUFACTURERS To deal with the COVID-19 outbreak challenges and increasing demand for the drugs, many market players are creating new strategies such as new product development, telemedicine, and a different program to support patients and to raise their sales. It is predicted that these strategies are anticipated to escalate up the company revenue and its growth in the forecasted period. The government has provided drug FDA approvals of nivolumab for the treatment of cancer. For instance, · In May 2020, Bristol Myers Company announced that Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (injections for intravenous use) was approved by the U.S. Food and Drug Administration (FDA) for the first-line treatment of adult patients with metastatic non-small cell lung cancer (NSCLC). · There are several ongoing potentially registrational studies that have been conducted by different manufacturing companies for Opdivo for the treatment of different tumor types and disease areas, in combination with various anti-cancer agents · Also, there are various ongoing clinical trials conducting on nivolumab with the combination of various anti-cancer agents and others to treat various types of cancer to decrease the demand for cancer treatment and to provide patients with more advanced drugs. For instance · In Japan, South Korea, and Taiwan, ONO pharmaceuticals are co-developing this drug nivolumab with the Bristol Myers Company IMPACT ON DEMAND Global economic development in 2020 has been severely impacted by the COVID-19 pandemic. The COVID-19 has given rise to risks such as a prolonged, significant decline in global demand as well as unfavorable geopolitical and macroeconomic effects. The coronavirus pandemic has provoked many strategical actions among healthcare providers on how to manage cancer patients when faced with the threat of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection. There has been a decrease in demand for nivolumab in some countries like the U.S., whereas many countries have seen an increase in sales with the rise in demand for the treatment and new cancer patients. With the rise in demand for the drug, FDA has provided approval to various drugs related to the immunotherapy nivolumab. For instance- · For the Bristol-Myers Squibb Company, the U.S. revenues of nivolumab decreased to 9% in 2020 due to lower demand caused by declining second-line eligibility across tumor indications and lower demand from COVID-19 (primarily lower new patient starts and patient visits). The U.S. has seen a decrease in sales in the first quarter of 2020. · However, the international revenues for nivolumab were increased up to 7% in 2020 due to higher demand as a result of additional indication launches in some countries with rising cancer patients globally. · In May 2021 -- Bristol-Myers Squibb Company has today announced that the U.S. Food and Drug Administration (FDA) had approved their Opdivo (nivolumab, injection for intravenous use) for the adjuvant treatment of completely resected esophageal or gastroesophageal junction (GEJ) cancer. · Similarly, FDA has approved Opdivo (nivolumab) for treating different types of cancer in many countries via various market players due to the rise in demand for this drug. IMPACT ON PRICE COVID-19 is significantly decreasing commercial activity in every area of the business sector. The economy has been decreased during the pandemic with the restricted and disrupted supply and sales of products and devices. The cost of medication and treatment of nivolumab has been increased due to the increasing demand for this drug during COVID-19. This contributed to the increased expenses and prices of immunotherapy drugs. Changes in the economy and other factors have caused consequences, including the decrease in the sales of the drug in some countries such as the U.S. With the rise of COVID-19 and decrease in new patients has also contributed to the increased cost and priced of some products and medication. · The price of Opdivo (nivolumab) drug which is a most common therapy treatment for various type of cancer or tumor have been increased to USD 1,172 for a supply of 4 milliliters of injection in 2020 with the rise in demand and increasing patients population in the second quarter of 2020. IMPACT ON SUPPLY CHAIN The COVID-19 pandemic has transformed many organizations’ business environments; supply availability has been hampered by a number of issues, including export and travel restrictions by some producing countries, and the lockdown has forced suppliers to (temporarily) shut down. The supply of nivolumab medication has a slight decrease in sales during the first quarter of 2020, partly due to negative factors mentioned above in connection with the COVID-19 pandemic, which particularly didn’t affect the overall yearly revenue. The pandemic and COVID-19 have affected every business activity in which the supply chain was affected the most. Because of the pertinacious COVID-19 lockdown, sanctions have been forced by administrations of different nations. These limitations and boundaries across the nation’s borders prompted a diminishing stockpile because of restricted materials and labor force and the halting of the assembly line. The supply chain and demand were positively affected by the COVID 19. The sales and supply of the drugs have been increased with the rise in demand for the drugs and diagnosis. Many major manufacturing companies have launched their drugs in different countries to fulfill the demand, and the government has provided approval for the sales of the drug nivolumab. For instance- Despite the pandemic, many market player of nivolumab has increased their sales globally. This is due to the ongoing increase in the patient population and rising awareness regarding their health. · The sales of ONO pharmaceuticals have been increased in the year 2020 as compared to 2019, which is 2656.05 USD Million in 2019 and 2809.23 USD million. · Similarly, sales of the drug Opdivo (Nivolumab) from the manufacturing company Bristol Myers Squibb Company have been increased globally (except the U.S.) from USD 2,860 million in 2019 to USD 3,047 million in 2020. This increase in sales in both of the major market players is due to the increase in cancer patients and the use of drugs in all areas of cancer. There is an increase in the sales of this nivolumab with the rise in prevalence of disease and early diagnosis & treatment. CONCLUSION As the pandemic of COVID-19 resulted in several restrictions throughout the borders, still, manufacturers and market players were able to manage their sales and revenue of oncology and drug nivolumab. Various manufacturers allowed their workers to work in a clean and safe environment so as to boost up the production at various manufacturing facilities across several regions of the world, thus, helping them to maintain a continuous supply chain with the increasing demand. Market players have come up with better strategies which have also created a positive impact on the growth of the nivolumab market globally.
What COVID-19 Impacted on Non-Small Cell Lung Cancer Diagnostics in Healthcare Industry ?
Impact of COVID-19 on Non-Small Cell Lung Cancer Diagnostics in Healthcare Industry The novel coronavirus has profoundly impacted all fields, including healthcare, medical device services, automotive, pharmaceutical and many others. This pandemic has led to shutdowns of mass production and disruptions in the supply chain that have impacted the economies of virtually every nation in the world. The pandemic also affected the non-small cell lung cancer diagnostic industry. The patient's fear of contracting the virus compels patients to stay home instead of undergoing diagnosis and treatment. As a result, the hospitals and clinics were filled up with COVID-19 patients and less preference was given to non-small cell lung cancer patients. Moreover, limited access to clinics, social distancing, the lockdown of the population, which results in a slow-down in patient flow and referrals, has also impacted the market growth. However, with the cases decreasing in number and increase in vaccination against COVID-19 across the globe, the market for non-small cell lung cancer diagnostics market may get a boost due to some relaxation in COVID-19 cases, which will result in increased demand for non-small cell lung cancer diagnosis with patients coming forward to clinics and hospitals for treatment. During the COVID-19 pandemic, countries worldwide witnessed a large number of patients suffering from COVID-19 and post COVID-19 complications such as cardiovascular disease, diabetes and kidney problems. As the COVID-19 cases were rising, the healthcare system had shifted its focus in curbing the disease, thereby delaying diagnosis and treatment of other chronic conditions as cancer. Thus, a negative impact is expected on the non-small cell lung cancer diagnostics market due to the pandemic scenario IMPACT ON PRICE The coronavirus disease (COVID-19) pandemic does not significantly impact the global non-small cell lung cancer diagnostics market. But it is estimated that if COVID-19 continues to spread for a prolonged period, then the demand for non-small cell lung cancer diagnostic equipment and devices will highly upsurge for top importer countries. For therapies and the diagnostic United States solicit the huge number of medical devices, followed by China and Japan. For instance, · According to the General Administration of Customs (GAC), China's exports of medical machinery and devices increased 40.5 percent in 2020 compared to the previous year, reaching USD 18.138 billion · According to the World Trade Organisation, the U.S. imports and exports of medical goods increased by 16 %, reaching USD 1,139.00 billion in value Henceforth for diagnosis, dependency of these countries highly increases on other exporters and many countries solely depend on China and the U.S. for the non-small cell lung cancer diagnostic equipment. Consequently, this may lead to a rise in the overall non-small cell lung cancer diagnostic cost. This increase in the price of the non-small cell lung cancer diagnostic may hamper the market growth if it continues to be the same. Additionally, if the lockdown continues to stretch for a long period, then import of non-small cell lung cancer diagnostics market is estimated to get more restricted, which may further lead to a rise in the price of the these devices IMPACT ON DEMAND Various screening, diagnostic and surgical procedures were restricted and at hospitals and cancer treatment centers, which resulted in disruptions in the non-small cell lung cancer diagnostics market. However, even during the pandemic, the lung cancer cases were subsequent, which is expected to increase the demand for non-small cell lung cancer diagnostics market. For instance, · According to World Health Organization (WHO), in 2020, lung cancer accounted for 2,206 771 deaths among both sexes. The lung cancer statistics include both small cell lung cancer and non-small cell lung cancer. About 13% of all lung cancers are small cell lung cancer and 84% are non-small cell lung cancer. This proves an increase in the number of non-small cell lung cancer patients even during the COVID-19 pandemic. Moreover, according to the American Cancer Society, Inc., lung cancer patients are likely to get infected with coronavirus because of the changes in their immune system that control their body's defense systems. For instance, · According to a study published in PubMed, patients with lung cancer are at an increased risk of becoming infected with the virus and experience higher morbidity and mortality than the general population Thus, having cancer such as non-small cell lung cancer may also increase the risk of severe illness from COVID-19 as the cancer therapy treatment reduce the immune system of the body. . This has increased the demand for non-small cell lung cancer diagnostic tools, especially in cancer-dedicated hospitals and surgical centres, where all the patients of non-small cell lung cancer-related problems are treated. Thus, with the increased lung cancer cases, the demand for non-small cell lung cancer diagnostic will increase in the coming years. IMPACT ON SUPPLY CHAIN The supply chain was widely affected by the COVID-19 pandemic as acute restrictions and lockdowns produced many urgent situations in the early days of the pandemic, which needed immediate attention. The supply chain disruption has transformed many organizations' business environments, including the supply chain of non-small cell lung cancer diagnostics market. The supply chain disruption impacted the Asia-Pacific region initially, especially the demand from China due to challenges from restricted movement and quarantine period. For instance, · According to the FDA, 63 manufacturers representing 72 facilities in China that produce essential medical devices face obstacles in manufacturing medical devices and their supply, owing to citing workforce challenges and the necessary quarantine of workers. Moreover, closing borders of various countries is anticipated to diminish the supply chain business environment, as it may hamper export of the medical supplies To minimize supply chain crises, the FDA has been firmly monitoring the supply chain with the assumption that the COVID-19 outbreak may adversely impact the supply chain of medical products, including shortages of critical medical products in the U.S. or potential disruptions in supply chains. Many organizations and countries are looking forward to improving and diversified supply chain models in all aspects to manage such a crucial situation. A diversified supply chain model anticipated minimizing the export of medical products as well as increase end-to-end visibility. For instance, · The Brazilian government published a resolution eliminating import taxes on 141 medical products and hospital equipment · The European Commission made a decision for helping Member States affected by the pandemic to suspend customs duties and VAT on medical devices temporarily · Federal indirect tax body the Goods and Services Tax (GST) Council of India has decided to cut taxes on medical supplies CONCLUSION It is estimated that the COVID-19 pandemic outbreak has significantly impacted the growth of non-small cell lung cancer diagnostics market as the rising cases of COVID-19 worldwide the healthcare system had shifted its focus in curbing the disease, thereby resulting in the delay of diagnosis and treatment of non-small cell lung cancer. Thus, a negative impact is expected on the non-small cell lung cancer diagnostics market due to the pandemic scenario. However, with the increase in lung cancer patients worldwide, the demand for non-small cell lung cancer diagnostics will increase in the coming years. Moreover, poor lifestyle, smoking, alcohol consumption, lack of physical activity and other factors will contribute to the incidence of chronic disease such as lung cancer, including non-small cell lung, which is anticipated to increase the global non-small cell lung cancer diagnostics market in the coming years.